WilliamWJowMD

Urology • Holmdel, NJ

Physician

Join to view full profile

Dr. Jow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jow's full profile

Already have an account?

Office
723 N Beers St
Ste 1F
Holmdel, NJ 07733
Phone+1 732-888-0809

Fax+1 732-888-5559

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1991 - 1993
University at BuffaloResidency, Urology, 1990 - 1991
Icahn School of Medicine at Mount SinaiResidency, Surgery, 1986 - 1988
New York University School of MedicineClass of 1986

Certifications & Licensure

NJ State Medical License 1993 - 2025
NY State Medical License 1987 - 2000
American Board of Urology Urology

Awards, Honors, & Recognition

Most Compassionate Doctor American Registry

Publications & Presentations

PubMed

82 citations
Motile sperm in human testis biopsy specimens
William W. Jow, Joph Steckel, Peter N. Schlegel, Margret S. Magid, Marc Goldstein
Journal of Andrology. 1993-05-06
12 citations
Malignant juxtadrenal schwannoma.
William Jow, Sateesh Satchidanand, Ernesto Spinazze, David Lillie
Urology. 1991-10-01
2 citations
Prolieve Transurethral Thermodilatation for treatment of Symptomatic Benign Prostatic Hyperplasia: 5-Year Results from a Prospective Multicenter Trial.
Ephrem Odoy Olweny, Steven L Jow, William W Jow
Journal of Endourology. 2021-11-01

Press Mentions

Medifocus Inc. : Medifocus, Inc. Expands Its Reach into the Israeli Market with Amos Gazit Ltd. For Its Prolieve(R) Thermodilatation for BPH Therapy and Announces Significant Debt Conversion into SharesJanuary 9th, 2018
Medifocus Inc. : Medifocus, Inc. Announces Significant Improvement in Operating Results for the Fiscal Year Ending March 31, 2017August 28th, 2017
Medifocus, Inc. Announces First Ever Quarterly Operating Profit and Significant Improvement in Operating Results for the Nine Months Ended December 31, 2016March 16th, 2017
Join now to see all